Cost of revenue · 2018–2025
Akebia Therapeutics cost of revenue
$39.5M−37.5% · FY2025
Akebia Therapeutics (AKBA) reported $39.5M in cost of revenue for fiscal 2025, −37.5% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $39.5M | −37.5% | Open → |
| FY20242024-12-31 | $63.2M | −14.8% | Open → |
| FY20232023-12-31 | $74.1M | −13.3% | Open → |
| FY20222022-12-31 | $85.6M | −43.2% | Open → |
| FY20212021-12-31 | $151M | −49.2% | Open → |
| FY20202020-12-31 | $296M | +104.0% | Open → |
| FY20192019-12-31 | $145M | +1,771.0% | Open → |
| FY20182018-12-31 | $7.8M | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +26.1%
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Akebia Therapeutics cost of revenue |url=https://companiesranked.com/en/company/akebia-therapeutics/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Akebia Therapeutics cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/akebia-therapeutics/cost-of-revenueBibTeX
@misc{companiesranked-en-company-akebia-therapeutics-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Akebia Therapeutics cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/akebia-therapeutics/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001517022-26-000020 · February 26, 2026
{{cite web |title=Akebia Therapeutics cost of revenue — 10-K (0001517022-26-000020) |url=https://www.sec.gov/Archives/edgar/data/1517022/000151702226000020/akba-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.